• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多西拉敏的药代动力学:采用带氮磷检测的自动气相色谱法

The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection.

作者信息

Friedman H, Greenblatt D J

出版信息

J Clin Pharmacol. 1985 Sep;25(6):448-51. doi: 10.1002/j.1552-4604.1985.tb02875.x.

DOI:10.1002/j.1552-4604.1985.tb02875.x
PMID:4056080
Abstract

Sixteen healthy male volunteers received a single oral dose of 25 mg doxylamine succinate. Doxylamine concentrations in plasma were measured by a newly developed gas chromatographic methodology, utilizing direct alkaline extraction into hexane:isoamyl alcohol followed by concentration and autoinjection. Doxylamine kinetics were determined from multiple plasma doxylamine concentrations measured during the 24 hours postdose. Mean kinetic variables were: peak plasma level, 99 ng/mL; time of peak, 2.4 hours postdose; elimination half-life, 10.1 hours; and apparent oral clearance, 217 mL/min. Analogous analytic methodology can be used to study the pharmacokinetics of other drugs of this class.

摘要

16名健康男性志愿者单次口服25毫克琥珀酸多西拉敏。血浆中的多西拉敏浓度通过一种新开发的气相色谱方法测定,该方法采用直接碱性萃取到己烷:异戊醇中,然后进行浓缩和自动进样。多西拉敏动力学由给药后24小时内多次测量的血浆多西拉敏浓度确定。平均动力学变量为:血浆峰值水平99纳克/毫升;峰值时间为给药后2.4小时;消除半衰期为10.1小时;表观口服清除率为217毫升/分钟。类似的分析方法可用于研究此类其他药物的药代动力学。

相似文献

1
The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection.多西拉敏的药代动力学:采用带氮磷检测的自动气相色谱法
J Clin Pharmacol. 1985 Sep;25(6):448-51. doi: 10.1002/j.1552-4604.1985.tb02875.x.
2
Doxylamine and diphenhydramine pharmacokinetics in women on low-dose estrogen oral contraceptives.低剂量雌激素口服避孕药女性中多西拉敏和苯海拉明的药代动力学
J Clin Pharmacol. 1989 Mar;29(3):257-60. doi: 10.1002/j.1552-4604.1989.tb03323.x.
3
Analysis of doxylamine in plasma by high-performance liquid chromatography.采用高效液相色谱法分析血浆中的多西拉敏。
J Pharm Sci. 1983 Aug;72(8):961-2. doi: 10.1002/jps.2600720834.
4
Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women.抗组胺药多西拉敏的清除率。老年男性降低,但老年女性未降低。
Clin Pharmacokinet. 1989 May;16(5):312-6. doi: 10.2165/00003088-198916050-00003.
5
Metabolism of doxylamine succinate in Fischer 344 rats. Part II: Nonconjugated urinary and fecal metabolites.富氏344大鼠中琥珀酸多西拉敏的代谢。第二部分:非结合的尿液和粪便代谢物。
J Anal Toxicol. 1987 May-Jun;11(3):113-21. doi: 10.1093/jat/11.3.113.
6
Metabolism of 14C-labeled doxylamine succinate (Bendectin) in the rhesus monkey (Macaca mulatta).恒河猴(猕猴属)体内14C标记的琥珀酸多西拉敏(敏克静)的代谢
J Anal Toxicol. 1986 May-Jun;10(3):87-92. doi: 10.1093/jat/10.3.87.
7
Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.大鼠经鼻内、口服和静脉注射单剂量琥珀酸多西拉敏后的比较药代动力学。
Biopharm Drug Dispos. 2002 Sep;23(6):239-44. doi: 10.1002/bdd.314.
8
Pharmacokinetics of doxylamine, a component of Bendectin, in the rhesus monkey.多西拉敏(一种抗敏安成分)在恒河猴体内的药代动力学。
Reprod Toxicol. 1989;3(3):187-96. doi: 10.1016/0890-6238(89)90006-3.
9
Metabolism of doxylamine succinate in Fischer 344 rats. Part III: Conjugated urinary and fecal metabolites.琥珀酸多西拉敏在Fischer 344大鼠中的代谢。第三部分:尿和粪便中的共轭代谢物。
J Anal Toxicol. 1990 Jul-Aug;14(4):247-51. doi: 10.1093/jat/14.4.247.
10
Identification in in vivo acetylation pathway for N-dealkylated metabolites of doxylamine in humans.人体内多西拉敏N-脱烷基代谢产物的体内乙酰化途径鉴定。
Xenobiotica. 1987 Aug;17(8):993-9. doi: 10.3109/00498258709044198.

引用本文的文献

1
A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment.一项评估慢性间歇性睡眠障碍患者经鼻给予多西拉敏的药代动力学和药效学的 I 期研究。
Drugs R D. 2018 Jun;18(2):129-136. doi: 10.1007/s40268-018-0232-1.
2
Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety.用于治疗偶尔性睡眠障碍或短暂性失眠的非处方药物:疗效与安全性的系统评价
Prim Care Companion CNS Disord. 2015 Dec 31;17(6). doi: 10.4088/PCC.15r01798. eCollection 2015.
3
Pharmacokinetic dose proportionality between two strengths (12.5 mg and 25 mg) of doxylamine hydrogen succinate film-coated tablets in fasting state: a single-dose, randomized, two-period crossover study in healthy volunteers.
在禁食状态下,琥珀酸多西拉敏两种规格(12.5 毫克和 25 毫克)薄膜包衣片的药代动力学剂量比例:一项在健康志愿者中进行的单次、随机、两周期交叉研究。
Drugs R D. 2013 Jun;13(2):129-35. doi: 10.1007/s40268-013-0015-7.
4
Food effects on the pharmacokinetics of doxylamine hydrogen succinate 25 mg film-coated tablets: a single-dose, randomized, two-period crossover study in healthy volunteers.食物对琥珀酸多西拉敏 25mg 薄膜包衣片药代动力学的影响:一项在健康志愿者中进行的单次、随机、两周期交叉研究。
Drugs R D. 2012 Dec 1;12(4):217-25. doi: 10.2165/11641640-000000000-00000.
5
A fatal complication of doxylamine in a 1-year-old girl.一名1岁女童服用多西拉敏后的致命并发症。
Int J Legal Med. 2012 May;126(3):447-9. doi: 10.1007/s00414-011-0577-2. Epub 2011 Jul 2.
6
Doxylamine toxicity: seizure, rhabdomyolysis and false positive urine drug screen for methadone.多西拉敏中毒:癫痫发作、横纹肌溶解以及美沙酮尿液药物筛查假阳性。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0879. Epub 2009 Mar 17.
7
Switching drug availability from prescription only to over-the-counter status. Are elderly patients at increased risk?将药品供应从仅凭处方购买改为非处方状态。老年患者的风险会增加吗?
Drugs Aging. 1995 Oct;7(4):255-65. doi: 10.2165/00002512-199507040-00001.
8
Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women.抗组胺药多西拉敏的清除率。老年男性降低,但老年女性未降低。
Clin Pharmacokinet. 1989 May;16(5):312-6. doi: 10.2165/00003088-198916050-00003.